Skip to main content
TipRanks
Go Ultimate75% OFF

Imunon (0HUZ) Financial Statements

2 Followers

Imunon Financial Overview

Imunon's market cap is currently $3.85M. The company's EPS TTM is $-4.01; its P/E ratio is -0.15; and it has a dividend yield of 11.75%. Imunon is estimated to report earnings on April 1, 2027, and the estimated EPS forecast is $-0.50. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Mar 26Dec 24Dec 23Dec 22Mar 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 500.00K$ 500.00K
Gross Profit$ 0.00$ 0.00$ 0.00$ 500.00K$ 500.00K
Operating Income$ -14.65M$ -19.13M$ -21.03M$ -24.92M$ -21.01M
EBITDA$ -13.80M$ -17.90M$ -19.88M$ -31.71M$ -20.88M
Net Income$ -14.49M$ -18.62M$ -19.51M$ -35.90M$ -20.77M
Balance Sheet
Cash & Short-Term Investments$ 8.78M$ 5.87M$ 15.70M$ 32.75M$ 49.39M
Total Assets$ 12.29M$ 9.72M$ 21.92M$ 43.98M$ 74.05M
Total Debt$ 1.01M$ 1.14M$ 1.62M$ 6.27M$ 6.63M
Net Debt$ -7.77M$ -4.73M$ -4.21M$ -5.23M$ -12.95M
Total Liabilities$ 5.23M$ 5.47M$ 8.53M$ 14.65M$ 18.25M
Stockholders' Equity$ 7.06M$ 4.24M$ 13.39M$ 29.33M$ 55.80M
Cash Flow
Free Cash Flow$ -14.18M$ -18.88M$ -19.47M$ -23.36M$ -16.54M
Operating Cash Flow$ -13.90M$ -18.85M$ -19.02M$ -23.10M$ -16.22M
Investing Cash Flow$ -280.57K$ 9.83M$ 11.01M$ 8.28M$ -30.12M
Financing Cash Flow$ 17.09M$ 9.06M$ -3.64M$ 6.72M$ 54.77M

Currency in USD

Imunon Earnings and Revenue History

-40M-20M020M-8000 %-6000 %-4000 %-2000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

Imunon Liabilities to Assets

030M60M90M20 %40 %60 %80 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Imunon Cash Flow

-40M-20M020M40M60M201720182019202020212022202320242025OperatingInvestingFinancing

Imunon Forecast EPS vs Actual EPS

-1.4-1.2-1-0.8-0.6-0.4Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss